NovaBridge Biosciences (NBP) Non-Current Assets (2018 - 2022)
NovaBridge Biosciences (NBP) has disclosed Non-Current Assets for 5 consecutive years, with $201.4 million as the latest value for Q4 2022.
- Quarterly Non-Current Assets rose 6.67% to $201.4 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $201.4 million through Dec 2022, up 6.67% year-over-year, with the annual reading at $201.4 million for FY2022, 6.67% up from the prior year.
- Non-Current Assets for Q4 2022 was $201.4 million at NovaBridge Biosciences, up from $188.8 million in the prior quarter.
- The five-year high for Non-Current Assets was $201.4 million in Q4 2022, with the low at $49.0 million in Q4 2018.
- Average Non-Current Assets over 5 years is $123.0 million, with a median of $122.3 million recorded in 2020.
- The sharpest move saw Non-Current Assets soared 129.13% in 2020, then grew 6.67% in 2022.
- Over 5 years, Non-Current Assets stood at $49.0 million in 2018, then rose by 8.85% to $53.4 million in 2019, then skyrocketed by 129.13% to $122.3 million in 2020, then soared by 54.36% to $188.8 million in 2021, then increased by 6.67% to $201.4 million in 2022.
- According to Business Quant data, Non-Current Assets over the past three periods came in at $201.4 million, $188.8 million, and $122.3 million for Q4 2022, Q4 2021, and Q4 2020 respectively.